Valvular & structural heart disease

Single- Versus Dual-Access Transcatheter Aortic Valve Implantation Using Balloon-Expandable Platform: A Propensity Score Matching Study

JACC AdvPublished retrospective analysis of consecutive patients

Authors' conclusion

SA is a feasible and safe strategy compared to DA TAVI. It was associated with quicker procedure times, lower contrast and radiation exposure, and a better 30-day safety profile than the DA strategy. Future randomized studies are needed to further assess this strategy.

Study context

Population
Consecutive patients who underwent transfemoral transcatheter aortic valve implantation (TAVI) using balloon-expandable valve Sapien 3 Ultrapatients who had transfemoral TAVI, 117 (22%) underwent single access (SA), matched cohort 204 patients (102 in each group)
Participants
532 patients
Exposure
SA vs dual access (DA) TAVI
  • SAn = 102
  • DAn = 102reference
Outcome
Co-primary endpoints: device success and 30-day safety endpoints (Valve Academic Research Consortium 3)
Follow-up
30 days
Methodological detailspropensity score matching with a 1:1 ratio, data prospectively entered into a dedicated web-based database
  • Propensity score matching with a 1:1 ratio
  • Data prospectively entered into a dedicated web-based database

Main finding

As reported in the abstract

SA

Device success
3.9%
30-day safety profile
15.0%

DA

Device success
3.9%
30-day safety profile
28.9%

Device success

SA3.9%
DA3.9%

30-day safety profile

SA15.0%
DA28.9%
SA vs DAOdds ratio (95% CI)P value
Device success
1.00(0.24–4.11)
P > 0.99
30-day safety profile
0.44(0.22–0.88)
P = 0.02

Observational data: associations, not effects.

Further findings

SA was associated with a significant reduction in contrast use, fluoroscopy time, radiation exposure, and total procedure time

Original publication

Single- Versus Dual-Access Transcatheter Aortic Valve Implantation Using Balloon-Expandable Platform: A Propensity Score Matching Study. JACC Adv. Published 21 August 2025. doi:10.1016/j.jacadv.2025.102086

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.